GDRXNasdaqServices-Computer Processing & Data PreparationFiscal year ends December 31
GoodRx Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$3.37+0.01 (+0.30%)
Close on Oct 19, 2026
- Market cap
- $1.17B
- P/E (TTM)
- 84.3
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2017 to 2025
Gross margin
92.8%−1.9 pts over 5 years
Operating margin
11.0%+61.0 pts over 5 years
Net margin
3.8%+57.1 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +0.6% | +1.3% | +7.7% | – | |
| Gross profit | -0.7% | +1.8% | +7.2% | – | |
| Operating income | +32.9% | +269.2% | – | – | |
| Net income | +85.7% | – | – | – | |
| EPS, diluted | +125.0% | – | – | – | |
| Free cash flow | -10.0% | +4.8% | +8.2% | – |
Returns and balance sheet
9 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2017 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | – | 156.1% | 4.5% | |
| Return on assets | – | -31.6% | 2.2% | |
| Current ratio | – | 18.24 | 2.61 | |
| Debt to equity | – | 0.94 | 0.79 | |
| Net debt to EBITDA | – | 1.17× | 1.31× | |
| Interest coverage | – | -9.9× | 2.1× | |
| Capex to revenue | – | 3.7% | 0.4% | |
| Diluted shares | – | 275M | 357M |
Where the cash went
Fiscal 2021 to 2025, five years combined
GoodRx generated $815.65M from operations and spent $595.25M on capital expenditure, dividends and share buybacks. 2% of that went back into the business.
Generated
$815.65M
Used
$595.25M
Capital expenditure$14.34M2%Dividends$00%Share buybacks$580.91M98%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin3.8%
×Asset turnover0.57×
×Equity multiplier2.08×
=Return on equity, FY20254.5%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 3.8% | 0.57× | 2.08× | 4.5% |
| FY2024 | 2.1% | 0.53× | 2.00× | 2.2% |
| FY2023 | -1.2% | 0.47× | 2.03× | -1.1% |
| FY2022 | -4.3% | 0.48× | 1.95× | -4.0% |
| FY2021 | -3.4% | 0.48× | 1.99× | -3.3% |
| FY2020 | -53.3% | 0.59× | -4.94× | 156.1% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
7of 9 tests passed in fiscal 2025. Scores of 7 to 9 are usually read as strong.
- ProfitableNet income above zero$30.44M
- Cash generatingOperating cash flow above zero$167.90M
- Return on assets improvedROA up on the prior year1.0% → 2.2%
- Earnings backed by cashOperating cash flow above net income$167.90M vs $30.44M
- Less leverageLong-term debt to assets fell35.1% → 34.4%
- Better liquidityCurrent ratio rose5.32 → 2.61
- No dilutionShare count did not rise392M → 357M
- Gross margin improvedGross margin up on the prior year93.91% → 92.77%
- More efficientAsset turnover rose0.50 → 0.57